Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome
NCT01781234
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Tobacco Abstinence Syndrome
Interventions
DRUG:
Intranasal Insulin
DRUG:
Placebo
Sponsor
Ajna Hamidovic